AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24 | -31.4% | 17,595 | -0.3% | 0.00% | -50.0% |
| Q4 2022 | $35 | -100.0% | 17,653 | -68.2% | 0.00% | -50.0% |
| Q3 2022 | $112,000 | -44.0% | 55,522 | -11.7% | 0.00% | -33.3% |
| Q2 2022 | $200,000 | -23.7% | 62,846 | +0.2% | 0.01% | 0.0% |
| Q1 2022 | $262,000 | -24.1% | 62,739 | -12.9% | 0.01% | -14.3% |
| Q4 2021 | $345,000 | -9.9% | 72,022 | +0.5% | 0.01% | -22.2% |
| Q3 2021 | $383,000 | 0.0% | 71,691 | -4.1% | 0.01% | +28.6% |
| Q2 2021 | $383,000 | -19.5% | 74,771 | +5.7% | 0.01% | -30.0% |
| Q1 2021 | $476,000 | +131.1% | 70,721 | +56.9% | 0.01% | +150.0% |
| Q4 2020 | $206,000 | +15.1% | 45,079 | +256.2% | 0.00% | 0.0% |
| Q1 2019 | $179,000 | +4.7% | 12,657 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $171,000 | -43.9% | 12,657 | -8.0% | 0.00% | -33.3% |
| Q3 2018 | $305,000 | – | 13,757 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |